CK Life Sciences International Holdings (HKSE:00775) Change In Receivables : HK$0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is CK Life Sciences International Holdings Change In Receivables?

CK Life Sciences International Holdings's change in receivables for the quarter that ended in Dec. 2023 was HK$0 Mil. It means CK Life Sciences International Holdings's Accounts Receivable stayed the same from Jun. 2023 to Dec. 2023 .

CK Life Sciences International Holdings's change in receivables for the fiscal year that ended in Dec. 2023 was HK$51 Mil. It means CK Life Sciences International Holdings's Accounts Receivable declined by HK$51 Mil from Dec. 2022 to Dec. 2023 .

CK Life Sciences International Holdings's Accounts Receivable for the quarter that ended in Dec. 2023 was HK$894 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. CK Life Sciences International Holdings's Days Sales Outstanding for the six months ended in Dec. 2023 was 59.45.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. CK Life Sciences International Holdings's liquidation value for the six months ended in Dec. 2023 was HK$-5,109 Mil.

CK Life Sciences International Holdings Change In Receivables Historical Data

The historical data trend for CK Life Sciences International Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings Change In Receivables Chart

CK Life Sciences International Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

94.90

251.17

-117.36

-189.54

51.43

CK Life Sciences International Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

CK Life Sciences International Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

CK Life Sciences International Holdings (HKSE:00775) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

CK Life Sciences International Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	893.688	/	2743.605	*	91
=	59.45

2. In Ben Graham's calculation of liquidation value, CK Life Sciences International Holdings's accounts receivable are only considered to be worth 75% of book value:

CK Life Sciences International Holdings's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	676.163	-	7058.157	+	0.75 * 893.688	+	0.5 * 1204.538
=	-5,109

CK Life Sciences International Holdings Change In Receivables Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

CK Life Sciences International Holdings (HKSE:00775) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (HKSE:00775) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

LSI:Germany

Address

2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG

Website

https://www.ck-lifesciences.com

CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.

CK Life Sciences International Holdings (HKSE:00775) Headlines

No Headlines